Enveric Biosciences Inc (ENVB) — Strategic Asset Allocation Index
Enveric Biosciences Inc (ENVB) has a Strategic Asset Allocation Index of 12.4% as of June 2023. Strategic assets (PP&E of $604.84K plus long-term investments of $-) total $604.84K, measured against net assets of $4.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ENVB net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Enveric Biosciences Inc Strategic Asset Allocation Index (2021–2021)
This chart shows how Enveric Biosciences Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of June 2023, the index stands at 12.4%, representing strategic assets of $604.84K against net assets of $4.87 Million USD. For live market cap and overall valuation, see market value of Enveric Biosciences Inc.
Annual Strategic Asset Allocation Index for Enveric Biosciences Inc (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Enveric Biosciences Inc from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Enveric Biosciences Inc shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 2.1% | $470.73K | $470.73K | $- | $22.31 Million | — |